Advertisement
Screener

Zyla Life Sciences Stock-Based Compensation

Zyla Life Sciences Stock-Based Compensation

Zyla Life Sciences reported Stock-Based Compensation of $566.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2020-05-14

  • Zyla Life Sciences share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $566.00K.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $879.00K, a 1.97% increase year-over-year.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $1.14M, a 32.70% decline year-over-year.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $1.00M, a 36.14% decline year-over-year.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for fiscal 2018 was $3.97M, a 32.87% decline from fiscal 2017.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for fiscal 2017 was $5.92M, a 6.41% decline from fiscal 2016.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for fiscal 2016 was $6.32M, a 21.62% increase from fiscal 2015.
  • Zyla Life Sciences share-based payment arrangement, noncash expense for fiscal 2015 was $5.20M, a 38.96% decline from fiscal 2014.
Period endShare-based Payment Arrangement, Noncash Expense 1 monthShare-based Payment Arrangement, Noncash Expense 2 monthShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 5 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 8 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 11 monthShare-based Payment Arrangement, Noncash Expense 12 month
2020-03-31$566.00K
10-Q · filed 2020-05-14
2019-12-31$2.24M
10-K · filed 2020-03-26
2019-09-30$1.89M
10-Q · filed 2019-11-14
2019-06-30$877.00K
10-Q · filed 2019-08-13
2019-03-31$60.00K
10-Q · filed 2020-05-14
2019-01-31$4.13M
10-Q · filed 2020-05-14
2018-12-31$879.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$2.02M
derived: sum of 2 quarters · filed 2020-03-26
$3.02M
derived: sum of 3 quarters · filed 2020-03-26
$3.97M
10-K · filed 2020-03-26
2018-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$2.14M
derived: sum of 2 quarters · filed 2019-11-14
$3.09M
10-Q · filed 2019-11-14
$3.96M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.95M
10-Q · filed 2018-08-09
$2.82M
derived: sum of 3 quarters · filed 2019-03-29
$4.51M
derived: sum of 4 quarters · filed 2019-03-29
2018-03-31$952.00K
10-Q · filed 2018-05-10
$1.81M
derived: sum of 2 quarters · filed 2019-03-29
$3.51M
derived: sum of 3 quarters · filed 2019-03-29
$5.08M
derived: sum of 4 quarters · filed 2019-03-29
2017-12-31$862.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$2.56M
derived: sum of 2 quarters · filed 2019-03-29
$4.13M
derived: sum of 3 quarters · filed 2019-03-29
$5.92M
10-K · filed 2019-03-29
2017-09-30$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19
$3.26M
derived: sum of 2 quarters · filed 2018-11-19
$5.06M
10-Q · filed 2018-11-19
$6.70M
derived: sum of 4 quarters · filed 2018-11-19
2017-06-30$1.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$3.36M
10-Q · filed 2018-08-09
$5.01M
derived: sum of 3 quarters · filed 2018-08-09
$6.82M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$1.79M
10-Q · filed 2018-05-10
$3.44M
derived: sum of 2 quarters · filed 2018-05-10
$5.25M
derived: sum of 3 quarters · filed 2018-05-10
$6.80M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$3.46M
derived: sum of 2 quarters · filed 2018-03-16
$5.01M
derived: sum of 3 quarters · filed 2018-03-16
$6.32M
10-K · filed 2018-03-16
2016-09-30$1.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$3.36M
derived: sum of 2 quarters · filed 2017-11-08
$4.68M
10-Q · filed 2017-11-08
$6.16M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$1.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.87M
10-Q · filed 2017-08-09
$4.35M
derived: sum of 3 quarters · filed 2018-03-16
$5.65M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$1.31M
10-Q · filed 2017-05-10
$2.80M
derived: sum of 2 quarters · filed 2018-03-16
$4.09M
derived: sum of 3 quarters · filed 2018-03-16
$5.40M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$2.78M
derived: sum of 2 quarters · filed 2018-03-16
$4.08M
derived: sum of 3 quarters · filed 2018-03-16
$5.20M
10-K · filed 2018-03-16
2015-09-30$1.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$2.60M
derived: sum of 2 quarters · filed 2016-11-08
$3.71M
10-Q · filed 2016-11-08
$4.73M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$2.42M
10-Q · filed 2016-08-05
$3.43M
derived: sum of 3 quarters · filed 2017-03-13
$5.43M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$1.11M
10-Q · filed 2016-05-10
$2.13M
derived: sum of 2 quarters · filed 2017-03-13
$4.13M
derived: sum of 3 quarters · filed 2017-03-13
$7.95M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$3.01M
derived: sum of 2 quarters · filed 2017-03-13
$6.83M
derived: sum of 3 quarters · filed 2017-03-13
$8.52M
10-K · filed 2017-03-13
2014-09-30$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$5.82M
derived: sum of 2 quarters · filed 2015-11-06
$7.50M
10-Q · filed 2015-11-06
2014-06-30$3.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$5.51M
10-Q · filed 2015-08-07
2014-03-31$1.68M
10-Q · filed 2015-05-08